Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, John Fox, Vice President of Global Payroll at Johnson & Johnson and Vice President of Information Technology at Pharmaceuticals Group, addresses the financial considerations that will drive critical global clinical trial decision making over the next decade.
Cost has always been a critical factor when planning and conducting a clinical trial. The price tag to bring a drug to market today is more than $2 billion USD. As regulatory authorities throughout the world become more demanding regarding data quality and volume, it is crucial from both a financial and operational perspective to manage data sets optimally. In the past, the industry dealt with smaller and less complex data sets. It’s a lot more challenging today. Hence the need for more efficient data management applications.